These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24815311)

  • 21. Influence of formulation properties on chemical stability of captopril in aqueous preparations.
    Kristensen S; Lao YE; Brustugun J; Braenden JU
    Pharmazie; 2008 Dec; 63(12):872-7. PubMed ID: 19177902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Degradation kinetics and mechanism of RH1, a new anti-tumor agent: a technical note.
    Jain N; Machatha SG; Tabibi SE; Yalkowsky SH
    AAPS PharmSciTech; 2007 Mar; 8(1):16. PubMed ID: 17408216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Influence of Pluronic F68 and F127 Nanocarrier on Physicochemical Properties,
    Shaarani S; Hamid SS; Mohd Kaus NH
    Pharmacognosy Res; 2017; 9(1):12-20. PubMed ID: 28250648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stability of GR63178A, a novel pentacyclic pyrroloquinone anticancer compound, in aqueous solutions and biological fluids.
    French RC; Cummings J; Nicolson M; Smyth JF
    J Pharm Pharmacol; 1993 Jan; 45(1):10-5. PubMed ID: 8094437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Degradation kinetics of water-insoluble lauroyl-indapamide in aqueous solutions: prediction of the stabilities of the drug in liposomes.
    Suo XB; Deng YJ; Zhang H; Wang YQ
    Arch Pharm Res; 2007 Jul; 30(7):876-83. PubMed ID: 17703741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of degradation kinetics for abamectin in formulations using a stability indicating method.
    Awasthi A; Razzak M; Al-Kassas R; Harvey J; Garg S
    Acta Pharm; 2013 Mar; 63(1):59-69. PubMed ID: 23482313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isothermal and nonisothermal decomposition of famotidine in aqueous solution.
    Junnarkar GH; Stavchansky S
    Pharm Res; 1995 Apr; 12(4):599-604. PubMed ID: 7596998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Degradation kinetics of neostigmine in solution.
    Yeh MK
    Drug Dev Ind Pharm; 2000 Nov; 26(11):1221-6. PubMed ID: 11068698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preformulation studies on imexon.
    Kuehl PJ; Hoye WL; Myrdal PB
    Drug Dev Ind Pharm; 2006 Jul; 32(6):687-97. PubMed ID: 16885124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preformulation study of methazolamide for topical ophthalmic delivery: physicochemical properties and degradation kinetics in aqueous solutions.
    Jiang S; Wang F; Zhu S; Zhang X; Guo Z; Li R; Xu Q
    Int J Pharm; 2013 May; 448(2):390-3. PubMed ID: 23541985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral bioavailability enhancement and hepatoprotective effects of thymoquinone by self-nanoemulsifying drug delivery system.
    Kalam MA; Raish M; Ahmed A; Alkharfy KM; Mohsin K; Alshamsan A; Al-Jenoobi FI; Al-Mohizea AM; Shakeel F
    Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():319-329. PubMed ID: 28482534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Degradation kinetics of fluorouracil-acetic-acid-dextran conjugate in aqueous solution.
    Hao AJ; Deng YJ; Li TF; Suo XB; Cao YH; Hao YL; Zhang Y
    Drug Dev Ind Pharm; 2006 Jul; 32(6):757-63. PubMed ID: 16885130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stability of monoHER in an aqueous formulation for i.v. administration.
    Abou El Hassan MA; Touw DJ; Wilhelm AJ; Bast A; van der Vijgh WJ
    Int J Pharm; 2000 Dec; 211(1-2):51-6. PubMed ID: 11137338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An examination of carbopol hydrogel/organogel bigels of thymoquinone prepared by microwave irradiation method.
    Algin Yapar E; Tuncay Tanriverdi S; Aybar Tural G; Gümüş ZP; Turunç E; Gokce EH
    Drug Dev Ind Pharm; 2020 Oct; 46(10):1639-1646. PubMed ID: 32935592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of solvents and penetration enhancers on transdermal delivery of thymoquinone: permeability and skin deposition study.
    Haq A; Michniak-Kohn B
    Drug Deliv; 2018 Nov; 25(1):1943-1949. PubMed ID: 30463442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemical stability of teniposide in aqueous and parenteral lipid emulsions.
    Wang J; Cui Y; Tang X
    Drug Dev Ind Pharm; 2009 Apr; 35(4):508-13. PubMed ID: 18991092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the stability of linezolid in aqueous solution and commonly used intravenous fluids.
    Taylor R; Sunderland B; Luna G; Czarniak P
    Drug Des Devel Ther; 2017; 11():2087-2097. PubMed ID: 28744100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Degradation kinetics of 4-dedimethylamino sancycline, a new anti-tumor agent, in aqueous solutions.
    Pinsuwan S; Alvarez-Núñez FA; Tabibi ES; Yalkowsky SH
    Int J Pharm; 1999 Apr; 181(1):31-40. PubMed ID: 10370200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physicochemical characterization and an injection formulation study of water insoluble ZCVI₄-2, a novel NO-donor anticancer compound.
    Gao Y; Li L; Zhang J; Su F; Gong Z; Lai Y; Zhang Y
    Arch Pharm Res; 2012 Jul; 35(7):1177-86. PubMed ID: 22864740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incorporation of docetaxel and thymoquinone in borage nanoemulsion potentiates their antineoplastic activity in breast cancer cells.
    Alkhatib MH; Bawadud RS; Gashlan HM
    Sci Rep; 2020 Oct; 10(1):18124. PubMed ID: 33093596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.